Gina Ford Appointed CEO of BioNTX

BioNTX has announced the appointment of Gina Ford, DPh., MBA, as its new chief executive officer. This decision was made by the organisation's board of directors. In her role as…

CARsgen Therapeutics Reports 2025 Annual Results

SHANGHAI, March 6, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company dedicated to the development of innovative CAR T-cell therapies, has announced its annual results for…

A drug company with a side of gold?

Meghana Keshavan covers biotech and contributes to The Readout newsletter . Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech…